Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd.
Clinical trials sponsored by Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd., explained in plain language.
-
New shot could ease psoriatic arthritis pain
Disease control Recruiting nowThis study tests a new drug called picankibart for people with active psoriatic arthritis, a condition causing joint pain and skin patches. About 222 adults will get either the drug or a placebo shot to see if it reduces swelling and tenderness. The goal is to improve joint funct…
Phase: PHASE2, PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control
Last updated May 02, 2026 19:14 UTC
-
New hope for liver cancer: combination therapy trial launches
Disease control Recruiting nowThis study tests a combination of two drugs, IBI310 and sintilimab, as a first treatment for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if this combination can shrink tumors and help people live longer. About 680 participants will take…
Phase: PHASE2, PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC